Valuation — not yet established
No valuation for Dren Bio is on record yet — no priced round, mark, or trade has surfaced in our sources. Total raised ($181.2M) and the funding record below are the closest available signals.
Pro members can request priority coverage with a 48-hour turnaround.
Free account
See the evidence behind this price
- ·Post-money valuations for all 3 rounds
- ·The complete investor list — 17 names
- ·Watchlist + deal alerts for Dren Bio
Create free account
No card required
Funding history
3 rounds| Date | Round | Raised | Post-money | $/share |
|---|---|---|---|---|
| Mar 2022 | Later Stage VC | $62.5M | ▮ | ▮ |
| Aug 2020 | Early Stage VC | $25.5M | ▮ | ▮ |
| Jul 2019 | Early Stage VC | $5.1M | ▮ | ▮ |
How Dren Bio's valuation is determined
Private company valuations aren’t quoted on an exchange — they’re established in moments: a priced funding round sets a post-money valuation, secondary trades print at a price per share, and SEC-registered funds holding the stock report fair-value marks in their N-PORT filings.
For Dren Bio, too few pricing signals exist to publish a composite mark; the figures above reflect the most recent observed valuation event. Full methodology →
Frequently asked
- How much has Dren Bio raised?
- Dren Bio has raised $181.2M in total funding across 3 recorded rounds.
- When did Dren Bio last raise?
- Dren Bio last raised in Mar 2022 (Later Stage VC), raising $62.5M.